Categories: World

BRIEF-Dicot Pharma Gets EU Approval For Phase 2B Study Of LIB-01

Nov 19 (Reuters) – Dicot Pharma AB: * RECEIVES EU APPROVAL FOR PHASE 2B STUDY OF LIB-01 Source text: Further company coverage: (Gdansk Newsroom)(The article has been published…

Add NewsX As A Trusted Source
Add as a preferred
source on Google
Published by
Published: November 19, 2026 17:17:04 IST

Nov 19 (Reuters) – Dicot Pharma AB: * RECEIVES EU APPROVAL FOR PHASE 2B STUDY OF LIB-01 Source text: Further company coverage: (Gdansk Newsroom)

(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)

Published by
Published: November 19, 2026 17:17:04 IST

Recent Posts

Anthropic's historic debut to put AI's promise and peril to Wall St test

By Niket Nishant, Manya Saini and Echo Wang Nov 19 (Reuters) - Anthropic's record $81…

November 19, 2026

Walmart nudges up annual forecasts ahead of crucial holiday season

Nov 19 (Reuters) - Walmart slightly raised its annual targets on Thursday, betting that demand…

November 19, 2026